Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

524.28
-2.7200-0.52%
Post-market: 524.280.00000.00%19:26 EDT
Volume:796.63K
Turnover:417.78M
Market Cap:22.98B
PE:18.82
High:529.94
Open:522.58
Low:520.00
Close:527.00
52wk High:548.12
52wk Low:266.98
Shares:43.83M
Float Shares:41.99M
Volume Ratio:1.73
T/O Rate:1.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.86
EPS(LYR):27.86
ROE:19.71%
ROA:12.42%
PB:3.24
PE(LYR):18.82

Loading ...

United Therapeutics Director Jan Malcolm Reports Sale of Common Shares

Reuters
·
Dec 24, 2025

United Therapeutics Director Tommy G. Thompson Reports Disposal of Common Shares

Reuters
·
Dec 20, 2025

United Therapeutics Chairperson and CEO Martine A. Rothblatt reports disposal of common shares

Reuters
·
Dec 20, 2025

Will Insider Stock Sales Amid EXPAND Xenotransplantation Progress Change United Therapeutics' (UTHR) Narrative?

Simply Wall St.
·
Dec 18, 2025

United Therapeutics Director Christopher Patusky Reports Disposal of Common Shares

Reuters
·
Dec 17, 2025

United Therapeutics CEO Martine Rothblatt Reports Disposal of Common Shares

Reuters
·
Dec 13, 2025

United Therapeutics Director Nilda Mesa Reports Sale of Common Shares

Reuters
·
Dec 11, 2025

United Therapeutics President and COO Michael Benkowitz Reports Disposal of Common Shares

Reuters
·
Dec 10, 2025

How Investors Are Reacting To United Therapeutics (UTHR) Q3 Growth, 2027 Outlook and Insider Selling

Simply Wall St.
·
Dec 06, 2025

United Therapeutics CEO Martine Rothblatt Reports Disposal of Common Shares

Reuters
·
Dec 06, 2025

United Therapeutics CFO and Treasurer James Edgemond Reports Disposal of Common Shares

Reuters
·
Dec 03, 2025

United Therapeutics CEO Martine Rothblatt Reports Disposal of Common Shares

Reuters
·
Dec 02, 2025

Sustainable Investing Is Still Hot With Younger Investors. One Pro's Stock Picks. -- Barrons.com

Dow Jones
·
Dec 02, 2025

United Therapeutics CFO and Treasurer James Edgemond Reports Disposal of Common Shares

Reuters
·
Nov 27, 2025

United Therapeutics CEO Martine Rothblatt Reports Sale of Common Shares

Reuters
·
Nov 26, 2025

United Therapeutics CEO Martine Rothblatt Reports Disposal of Common Shares

Reuters
·
Nov 21, 2025

Jefferies Remains a Buy on United Therapeutics (UTHR)

TIPRANKS
·
Nov 19, 2025

United Therapeutics CFO James Edgemond Reports Disposal of Common Shares

Reuters
·
Nov 19, 2025

United Therapeutics EVP & General Counsel Paul A. Mahon Reports Disposal of Common Shares

Reuters
·
Nov 14, 2025

United Therapeutics CEO Martine Rothblatt Reports Disposal of Common Shares

Reuters
·
Nov 13, 2025